Troy Noordenbos

1.3k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Troy Noordenbos is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Troy Noordenbos has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 11 papers in Immunology and 8 papers in Hematology. Recurrent topics in Troy Noordenbos's work include Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Troy Noordenbos is often cited by papers focused on Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Troy Noordenbos collaborates with scholars based in Netherlands, Spain and United States. Troy Noordenbos's co-authors include Dominique Baeten, Paul P. Tak, Nataliya Yeremenko, Juan D. Cañete, Carmen A. Ambarus, Marleen van de Sande, Tineke Cantaert, Hulda S. Hreggvidsdottir, Bernard Vandooren and Iris C. Blijdorp and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Journal of Leukocyte Biology.

In The Last Decade

Troy Noordenbos

20 papers receiving 1.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

2024 93 citations Mark Hamilton, Takeshi Sugio et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Troy Noordenbos Netherlands	13	629	591	321	228	135	21	1.0k
Ariane Hammitzsch Germany	11	371 0.6×	288 0.5×	212 0.7×	316 1.4×	97 0.7×	18	816
B. Vitolo Italy	12	396 0.6×	281 0.5×	90 0.3×	111 0.5×	157 1.2×	20	727
PP Tak Netherlands	9	467 0.7×	256 0.4×	108 0.3×	208 0.9×	156 1.2×	38	910
Delphine Lemeiter France	14	220 0.3×	304 0.5×	65 0.2×	202 0.9×	148 1.1×	22	658
N. Kaibara Japan	14	226 0.4×	308 0.5×	79 0.2×	163 0.7×	130 1.0×	42	813
Hiroshi Koga Japan	24	1.0k 1.6×	131 0.2×	217 0.7×	127 0.6×	48 0.4×	106	1.7k
Karl Staser United States	19	98 0.2×	288 0.5×	211 0.7×	329 1.4×	332 2.5×	41	1.0k
Elisa Corsiero United Kingdom	12	291 0.5×	468 0.8×	58 0.2×	340 1.5×	115 0.9×	25	995
Ehsanollah Esfandiari United States	10	275 0.4×	258 0.4×	61 0.2×	103 0.5×	60 0.4×	23	669
Kazuhisa Nozawa Japan	17	283 0.4×	312 0.5×	40 0.1×	268 1.2×	98 0.7×	40	756

Countries citing papers authored by Troy Noordenbos

Since Specialization

Citations

This map shows the geographic impact of Troy Noordenbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Noordenbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Noordenbos more than expected).

Fields of papers citing papers by Troy Noordenbos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy Noordenbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Noordenbos. The network helps show where Troy Noordenbos may publish in the future.

Co-authorship network of co-authors of Troy Noordenbos

This figure shows the co-authorship network connecting the top 25 collaborators of Troy Noordenbos. A scholar is included among the top collaborators of Troy Noordenbos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy Noordenbos. Troy Noordenbos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamilton, Mark, Takeshi Sugio, Troy Noordenbos, et al.. (2024). Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. New England Journal of Medicine. 390(22). 2047–2060. 93 indexed citations breakdown →

Hamilton, Mark P., Takeshi Sugio, Troy Noordenbos, et al.. (2024). Absence of Evidence for Pervasive CAR19 Driven T-Cell Lymphomagenesis Revealed By Comprehensive Genomic Profiling of an Index Tumor.. Transplantation and Cellular Therapy. 30(2). S487–S488. 3 indexed citations

Chen, Sijia, Troy Noordenbos, Iris C. Blijdorp, et al.. (2018). Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content. Lara D. Veeken. 58(4). 617–627. 28 indexed citations

Blijdorp, Iris C., Silvia Menegatti, M. G. H. Van de Sande, et al.. (2018). Expansion of Interleukin‐22– and Granulocyte–Macrophage Colony‐Stimulating Factor–Expressing, but Not Interleukin‐17A–Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis. Arthritis & Rheumatology. 71(3). 392–402. 34 indexed citations

Paramarta, Jacqueline E, M. Turina, Troy Noordenbos, et al.. (2016). A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis. Journal of Translational Medicine. 14(1). 308–308. 18 indexed citations

Noordenbos, Troy, Iris C. Blijdorp, Sijia Chen, et al.. (2016). Human mast cells capture, store, and release bioactive, exogenous IL-17A. Journal of Leukocyte Biology. 100(3). 453–462. 67 indexed citations

Noordenbos, Troy, Iris C. Blijdorp, Hulda S. Hreggvidsdottir, et al.. (2015). AB0049 Human Type 1 Innate Lymphoid Cells Accumulate in the Inflamed Synovium in Spondyloarthritis. Annals of the Rheumatic Diseases. 74. 906–906. 4 indexed citations

Noordenbos, Troy, Iris C. Blijdorp, Leonieke van Mens, et al.. (2014). OP0226 Human Mast Cells Engulf and Store Exogenous IL-17A. Annals of the Rheumatic Diseases. 73. 147–147. 2 indexed citations

Turina, M., et al.. (2014). OP0156 Targeting Synovial Mast Cells in Spondyloarthritis: A Proof-Of-Concept Study with Nilotinib A Tyrosine Kinase Inhibitor. Annals of the Rheumatic Diseases. 73. 120–121. 3 indexed citations

10.

Hreggvidsdottir, Hulda S., Troy Noordenbos, & Dominique Baeten. (2013). Inflammatory pathways in spondyloarthritis. Molecular Immunology. 57(1). 28–37. 96 indexed citations

11.

Yeremenko, Nataliya, Troy Noordenbos, Tineke Cantaert, et al.. (2012). Disease‐specific and inflammation‐independent stromal alterations in spondylarthritis synovitis. Arthritis & Rheumatism. 65(1). 174–185. 52 indexed citations

12.

Ambarus, Carmen A., et al.. (2012). Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Research & Therapy. 14(2). 120 indexed citations

13.

Noordenbos, Troy, Nataliya Yeremenko, Marleen van de Sande, et al.. (2011). Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis & Rheumatism. 64(1). 99–109. 226 indexed citations

14.

Yeremenko, Nataliya, Troy Noordenbos, G. Rigter, et al.. (2011). Identification of robust and disease-specific stromal alterations in spondyloarthritis synovitis. Journal of Translational Medicine. 9(S2). 1 indexed citations

15.

Yeremenko, Nataliya, et al.. (2010). IL-17A producing mast cells as therapeutic target in spondyloarthritis. Journal of Translational Medicine. 8(S1). 1 indexed citations

16.

Vandooren, Bernard, Troy Noordenbos, Carmen A. Ambarus, et al.. (2009). Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis & Rheumatism. 60(4). 966–975. 130 indexed citations

17.

Cañete, Juan D., Raquel Celis, Troy Noordenbos, et al.. (2009). Distinct synovial immunopathology in Behçet disease and psoriatic arthritis. Arthritis Research & Therapy. 11(1). R17–R17. 38 indexed citations

18.

Vandooren, Bernard, Nataliya Yeremenko, Troy Noordenbos, et al.. (2009). Mediators of structural remodeling in peripheral spondylarthritis. Arthritis & Rheumatism. 60(12). 3534–3545. 11 indexed citations

19.

Vandooren, Bernard, Tineke Cantaert, Troy Noordenbos, Paul P. Tak, & Dominique Baeten. (2008). The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis & Rheumatism. 58(3). 718–729. 59 indexed citations

20.

Vandooren, Bernard, Tineke Cantaert, Troy Noordenbos, et al.. (2008). Tumor necrosis factor α drives cadherin 11 expression in rheumatoid inflammation. Arthritis & Rheumatism. 58(10). 3051–3062. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact